CLASS II ONGOING Device recall · Reported 23 Oct 2024 · FDA Enforcement Report

McKesson Cardiology Hemo recalled by Change Healthcare Canada

Change Healthcare Canada is recalling McKesson Cardiology Hemo, distributed nationwide in the US. The recall was initiated on 21 Aug 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI Numbers: (01)80010939050010(10)130201, (01)80010939050027(10)140000. Versions Versions 13.0, 13.1.1, 13.1.2, 13.2, 13.2.1, 14.0.
Quantity recalled35 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0128-2025
FDA event ID
95284
Recalling firm
Change Healthcare Canada, Richmond
Classification
Class II
Status
Ongoing
Recall initiated
21 Aug 2024
FDA classified
17 Oct 2024
Reported
23 Oct 2024
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Labeling Errors

Timeline

21 Aug 2024Recall initiated by company
17 Oct 2024Classified by FDA+57 days
23 Oct 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.

Product as listed by the FDA

McKesson Cardiology Hemo. Versions 13.0, 13.1.1, 13.1.2, 13.2, 13.2.1, 14.0.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.

Which lots are affected?

UDI Numbers: (01)80010939050010(10)130201, (01)80010939050027(10)140000. Versions Versions 13.0, 13.1.1, 13.1.2, 13.2, 13.2.1, 14.0.

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 95284

This product is part of a recall event; the main page for the event is Horizon Cardiology Hemo recalled by Change Healthcare Canada.

More recalls from Change Healthcare Canada

All 12

Other Other Medical Devices recalls

All 13,778